NARISSA SEELALL: Open Payments
NPI 1255007324 · CLERMONT, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,262 in 145 payments from 44 companies in 2025. Trend: 2023 $2,331 · 2024 $1,698 · 2025 $3,262
Food & beverage: $2,961Education: $302
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 13 | $240 |
| Merck Sharp & Dohme LLC | 11 | $239 |
| Janssen Biotech, Inc. | 9 | $227 |
| Novartis Pharmaceuticals Corporation | 14 | $224 |
| Daiichi Sankyo Inc. | 11 | $214 |
| AstraZeneca Pharmaceuticals LP | 6 | $170 |
| Eisai Inc. | 6 | $128 |
| Ipsen Biopharmaceuticals, Inc | 3 | $124 |
| Lilly USA, LLC | 4 | $122 |
| Astellas Pharma US Inc | 5 | $116 |
Products named: KEYTRUDA, Enhertu, Lenvima, KISQALI, Vyloy, ERLEADA, PLUVICTO, IMFINZI.
Industry payments across FL — which companies pay providers there.
